Literature DB >> 2286970

Behçet's syndrome treated with high-dose intravenous IgG and low-dose aspirin.

E Rewald1, J C Jaksic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2286970      PMCID： PMC1292866          DOI： 10.1177/014107689008301021

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  6 in total

1.  Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.

Authors:  K Masuda; A Nakajima; A Urayama; K Nakae; M Kogure; G Inaba
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

2.  Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.

Authors:  Y Sultan; M D Kazatchkine; P Maisonneuve; U E Nydegger
Journal:  Lancet       Date:  1984-10-06       Impact factor: 79.321

3.  Modulation of mononuclear phagocyte function by intravenous gamma-globulin.

Authors:  R P Kimberly; J E Salmon; J B Bussel; M K Crow; M W Hilgartner
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

4.  Transient neonatal Behcet's disease.

Authors:  M A Lewis; B L Priestley
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

5.  Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.

Authors:  A P Wilson; J Efthimiou; D J Betteridge
Journal:  Eur J Clin Invest       Date:  1988-08       Impact factor: 4.686

6.  Behçet's syndrome presenting as intracranial hypertension in a Caucasian.

Authors:  M Cobby; C M Higgs; C L Hall
Journal:  J R Soc Med       Date:  1988-08       Impact factor: 18.000
  6 in total
  4 in total

Review 1.  [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 2.  Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.

Authors:  Andreas Steinbrecher; Peter Berlit
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 3.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 4.  Update on the treatment of Behçet's syndrome.

Authors:  Sinem Nihal Esatoglu; Gulen Hatemi
Journal:  Intern Emerg Med       Date:  2019-01-25       Impact factor: 3.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.